Revvity Launches Signals AI to Advance Scientific R&D Workflows
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
Revvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript
Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics
Revvity (RVTY) Q1 Earnings and Revenues Top Estimates
Revvity Announces Financial Results for the First Quarter of 2026
Revvity to Report Q1 Earnings: What's in Store for the Stock?
Revvity Board Declares Quarterly Dividend
Sumitomo Mitsui Trust Group Inc. Has $3.46 Million Stock Position in Revvity Inc. $RVTY
Revvity to Present at Upcoming Investor Conferences
RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data
Revvity to Hold Earnings Call on Tuesday, May 5, 2026
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows
Revvity Gains on Diagnostics Strength, Faces China Headwinds
Allspring Global Investments Holdings LLC Raises Holdings in Revvity Inc. $RVTY
Revvity, Inc. (RVTY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report?
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Revvity to Present at Upcoming Investor Conferences
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
Revvity: Close To A Buy, Not Quite There
Here's Why Revvity (RVTY) is a Strong Momentum Stock
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives
Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
Revvity's Strong Performance Overshadowed by Market Uncertainty
Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates
Revvity (RVTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025
Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?
Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Revvity Board Declares Quarterly Dividend
Revvity (RVTY) Earnings Expected to Grow: Should You Buy?
Universal Beteiligungs und Servicegesellschaft mbH Sells 24,911 Shares of Revvity Inc. $RVTY
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Campbell & CO Investment Adviser LLC Purchases New Holdings in Revvity Inc. $RVTY
Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED)